Unknown

Dataset Information

HPV integration: a precise biomarker for detection of residual/recurrent disease after treatment of CIN2-3.


ABSTRACT:

Background

This study aimed to investigate whether persistent human papillomavirus integration at the same loci (PHISL) before and after treatment can predict recurrent/residual disease in women with CIN2-3.

Methods

A total of 151 CIN2-3 women treated with conization between August 2020 and September 2021 were included. To investigate the precision of HPV integration, we further analyzed HPV integration-positive patients. Sensitivity, specificity, positive and negative predictive values (PPV and NPV, respectively), and the Youden index for predicting recurrence/residual disease were calculated.

Results

Among the 151 enrolled CIN2-3 women, 56 were HPV integration-positive and 95 had HPV integration-negative results. Six (10.7%) experienced recurrence among 56 HPV integ

SUBMITTER: Huang F 

PROVIDER: S-EPMC11308599 | biostudies-literature | 2024 Aug

REPOSITORIES: biostudies-literature